Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Generalized glucocorticoid resistance causes hormone imbalances and varied symptoms due to gene mutations.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Certain gene variants are linked to severe acne, especially in males.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Testosterone may influence COVID-19 severity and outcomes.

Alopecia and acne in women are complex conditions needing coordinated care and personalized treatment.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

The patient likely has Chrousos syndrome, a rare condition causing insensitivity to glucocorticoids, requiring high-dose dexamethasone treatment.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

The gene URB is more active in human hair growth cells and responds to a hair-related hormone.

AR polyglycine repeat doesn't cause baldness.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.